CVS Surges 2.12% on Healthcare Reform Optimism and Strategic Moves Ranks 126th in $760M Volume

On September 9, 2025, , ranking it 126th among stocks traded that day. , outperforming broader market indices amid mixed sector performance. Analysts attributed the rise to renewed investor confidence in healthcare sector reforms and positive sentiment around the company's recent strategic initiatives.

Recent developments highlighted in market analyses included CVS's announced partnership with a leading pharmaceutical manufacturer to expand its over-the-counter product portfolio. The collaboration, expected to enhance retail pharmacy offerings, generated immediate market speculation about improved . Short-term traders noted elevated open interest in expiring in late October, suggesting speculative positioning ahead of potential earnings reports.

To evaluate this strategy rigorously, I’ll need to build a daily-rebalanced portfolio (equal-weight, . Before assembling data and running the back-test, clarification is required on universe definitions, weighting schemes, and transaction cost assumptions. These parameters will directly determine the accuracy of performance metrics and risk assessments for the proposed trading approach.